Harrow, Inc. (HROW)

47.06 -4.04 (-7.91%) USD  |  NASDAQ  |  Dec 12, 16:00
47.01 -0.05 (-0.11%) After-Hours: 20:00
More

Harrow Research and Development Expense (Quarterly): 3.323M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Assertio Holdings, Inc. 0.379M
Skye Bioscience, Inc. 9.178M
Theravance Biopharma, Inc. 7.707M
FibroGen, Inc. 1.209M
NovaBay Pharmaceuticals, Inc. --